These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30873491)

  • 21. Implementation of eHealth and AI integrated diagnostics with multidisciplinary digitized data: are we ready from an international perspective?
    Bukowski M; Farkas R; Beyan O; Moll L; Hahn H; Kiessling F; Schmitz-Rode T
    Eur Radiol; 2020 Oct; 30(10):5510-5524. PubMed ID: 32377810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalized Medicine and Medicinal Chemistry: Toward a Legal Framework in the European Union.
    Duardo-Sánchez A; De Miguel Beriain I
    Curr Top Med Chem; 2018; 18(25):2165-2173. PubMed ID: 30465506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of a personalized and distributed patient guidance system.
    Peleg M; Shahar Y; Quaglini S; Broens T; Budasu R; Fung N; Fux A; García-Sáez G; Goldstein A; González-Ferrer A; Hermens H; Hernando ME; Jones V; Klebanov G; Klimov D; Knoppel D; Larburu N; Marcos C; Martínez-Sarriegui I; Napolitano C; Pallàs À; Palomares A; Parimbelli E; Pons B; Rigla M; Sacchi L; Shalom E; Soffer P; van Schooten B
    Int J Med Inform; 2017 May; 101():108-130. PubMed ID: 28347441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Privacy Protection in Using Artificial Intelligence for Healthcare: Chinese Regulation in Comparative Perspective.
    Wang C; Zhang J; Lassi N; Zhang X
    Healthcare (Basel); 2022 Sep; 10(10):. PubMed ID: 36292325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial intelligence as a medical device in radiology: ethical and regulatory issues in Europe and the United States.
    Pesapane F; Volonté C; Codari M; Sardanelli F
    Insights Imaging; 2018 Oct; 9(5):745-753. PubMed ID: 30112675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARTIFICIAL INTELLIGENCE IN MEDICAL PRACTICE: REGULATIVE ISSUES AND PERSPECTIVES.
    Pashkov VM; Harkusha AO; Harkusha YO
    Wiad Lek; 2020; 73(12 cz 2):2722-2727. PubMed ID: 33611272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Working towards a national health information system in Australia.
    Bomba B; Cooper J; Miller M
    Medinfo; 1995; 8 Pt 2():1633. PubMed ID: 8591519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When is the processing of data from medical implants lawful? The legal grounds for processing health-related personal data from ICT implantable medical devices for treatment purposes under EU data protection law.
    Lindstad S; Ludvigsen KR
    Med Law Rev; 2023 Aug; 31(3):317-339. PubMed ID: 36282992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Privacy and Data Protection: A Review of Chinese Direct-to-Consumer Genetic Test Services.
    Du L; Wang M
    Front Genet; 2020; 11():416. PubMed ID: 32425986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of internet-based clinical decision support systems.
    Thomas KW; Dayton CS; Peterson MW
    J Med Internet Res; 1999; 1(2):E6. PubMed ID: 11720915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving patient informed consent for haemophilia gene therapy: the case for change.
    Woollard L; Gorman R; Rosenfelt DJ
    Ther Adv Rare Dis; 2021; 2():26330040211047244. PubMed ID: 37181114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Telecommunications, health and radiology: potential synergies for the new millennium].
    Lagalla R
    Radiol Med; 2001; 102(1-2):14-9. PubMed ID: 11677432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Information Privacy in Healthcare - The Vital Role of Informed Consent.
    McClelland R; Harper CM
    Eur J Health Law; 2022 Oct; 30(4):469-480. PubMed ID: 37582530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.